Correlations between Iron Metabolism Parameters, Inflammatory Markers and Lipid Profile Indicators in Patients with Type 1 and Type 2 Diabetes Mellitus

Autor: Tatiana V. Saprina, N. N. Musina, A. P. Zima, Tatiana S Prokhorenko, Alexander Kanev
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Journal of Personalized Medicine
Volume 10
Issue 3
Journal of Personalized Medicine, Vol 10, Iss 70, p 70 (2020)
ISSN: 2075-4426
Popis: This study aims to establish relationships between inflammatory status, ferrokinetics and lipid metabolism in patients with diabetes mellitus. Subclinical inflammation was assessed by levels of high-sensitive C-reactive protein, tumor necrosis factor-&alpha
and erythrocyte sedimentation rate. Iron metabolism parameters included complete blood count, serum iron, transferrin and ferritin. Metabolic status assessment included lipid profile, glycated hemoglobin and microalbuminuria measurement. As a result of the study it was possible to establish both general (universal) and diabetes mellitus (DM) type-dependent relationships between the parameters of lipid profile and metabolic control in DM. High-density lipoprotein cholesterol (HDL-C) levels negatively correlated with microalbuminuria (r = &minus
0.293
p ˂ 0.05 for type 1 diabetes and r = &minus
0.272
p ˂ 0.05 for type 2 diabetes). Ferritin concentration positively correlated with triglyceride level (r = 0.346
p ˂ 0.05 for type 1 diabetes and r = 0.244
p ˂ 0.05 for type 2 diabetes). In type 1 diabetes, a negative correlation was discovered between estimated glomerular filtration rate (eGFR) and LDL-C (r = &minus
0.480
p ˂ 0.05), very low-density-lipoprotein cholesterol (VLDL-C) (r = &minus
0.490
p ˂ 0.05) and triglycerides (r = &minus
0.553
p ˂ 0.05), and a positive one between C-reactive protein concentration and triglyceride level (r = 0.567
p ˂ 0.05). Discovered relationships between lipid profile indices, inflammatory status and microalbuminuria confirmed mutual influence of hyperlipidemia, inflammation and nephropathy in diabetes patients. Obtained results justify the strategy of early hypolipidemic therapy in patients with diabetes mellitus to prevent the development and progression of microvascular complications.
Databáze: OpenAIRE